Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nils Capital is a venture capital firm based in Zürich, Switzerland, focused on investing in small to mid-sized businesses. The firm has a track record of over 100 successful acquisitions and aims to support entrepreneurs through strategic investments and operational assistance. Nils Capital operates primarily in the DACH region, targeting sectors such as healthcare, biotech, consumer, edtech, and proptech.
Nils Capital invests in small to mid-sized businesses that demonstrate positive cash flows and possess a strong unique selling proposition. The firm emphasizes sectors with enduring growth potential and opportunities for consolidation, particularly those led by exceptional entrepreneurs. Their investment strategy includes a focus on innovation, commercial expansion, and corporate development, including mergers and acquisitions.
Nils Capital's portfolio includes notable companies such as Moxxis, a Swiss health-tech firm producing AI-powered, 3D-printed custom insoles; Pawoo, which enhances veterinary care through its investment in Amacker&Partner AG; Heimyo, a platform transforming property management in the DACH region; and neue Education, which invests in private K12 alternative education businesses.
Submit your pitch through their form at nilscapital.com.
Nils Capital typically participates in rounds but often collaborates with other investors to lead investments in promising companies.
The firm is open to follow-on investments, particularly in companies that demonstrate strong growth and operational success.
Specific details about the fund size are not publicly available, but Nils Capital focuses on small to mid-sized businesses with positive cash flows.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.